Oxford Textbook of Oncology

Featured on Doody's Core Titles List for 2018


Dr Andrew Davies, Consultant in Palliative Medicine, Royal Surrey County Hospital; Review for Supportive Care in Cancer I would recommend anyone considering buying an oncology textbook, and particularly those who work in oncology support services, to consider this textbook as it is well set out, easy to read, easy to comprehend, and covers all of the important aspects of modern day oncology.


Alexander A. Shtil, Recent Patents on Anticancer Drug Discovery An outstanding gift to the international scientific community... The new textbook is an excellent demonstration of this multifaceted and astonishingly variable problem, as well as of the latest achievements in its understanding and practical management.


Anticancer Research Vol. 36 (2016) This volume provides a comprehensive account of the multiple aspects of best practice in the discipline, making it an indispensable resource for oncologists of all grades and subspecialty interests.


Professor Jaak Ph. Janssens, European Journal of Cancer Prevention The Oxford Textbook of Oncology is what it is meant to be: a textbook with comprehensive information of the actual status of oncology... an indispensable and attractive source of information.


Oncology, Volume 63, 2002 Review from previous edition The Oxford Textbook of Oncology is a classic and fresh approach to the field. It is a must for all libraries and all those who like to have a single up-to-date reference book that contains sufficient detail for the clinician in all subspecialties: surgery and chapters are sufficiently details to provide a reference for trainees in the field.



NEJM, Volume 347, Number 2, 2002 The Oxford Textbook of Oncology covers virtually the entire spectrum of malignant diseases in adults and children. It meets very high editorial and production standards: the organization, illustrations, and eye-pleasing typography are outstanding... I have high praise for this textbook.



JAMA, Volume 287, Issue 24, 2002 Under new editorship, the second edition is far more than an updated version of the first...the prose in the Oxford Textbook is exemplary...this textbook is unique among its peers in giving the sense that the authors are addressing the reader personally...an exception level of qualityRespect for the evidence-based medicine is apparent throughout the text...illustrative and anatomical drawing...of remarkable high quality...excellent discussion of
doctor-patient communication in relation OT genetic counselling, psychological issues, and terminal cancers.



Biomedicine and Pharmacotherapy, 2002 A landmark referenceIt sets new standards for publishing in oncology offering a ground-breaking innovative approach to the filed combined with the quality, accuracy , and intellectual rigour you have come to expect from the world's most prestigious reference publisher.



Doody's Journal , 2002 This comprehensive tex...

David Kerr has made a sustained and internationally recognised contribution to cancer care and research in the field of medical oncology over the past three decades. He has published over 400 papers in high profile journals, authored over twenty books and has been awarded four prestigious, international research prizes, including the NHS's first Nye Bevan award for Innovation. His scientific standing has been recognised by election as Fellow of the Royal College of Physicians, Fellow of Academy of Medical Sciences, President of the European society of Medical Oncology (2009-2011) and Founding Fellow of the European Academy of Cancer Sciences.

SECTION 1: HALLMARKS OF CANCER ; 1. The hallmarks of cancer ; 2. Growth factors and uncontrolled proliferation ; 3. Cell signalling pathways ; 4. Cell cycle control ; 5. Cancer cell death ; 6. Angiogenesis ; 7. Invasion and metastases ; 8. Genetic instability ; 9. DNA repair after oncological therapy ; 10. Biology of cancer stem cells ; 11. Biomarker identification and clinical validation ; 12. Cancer, immunity, and inflammation ; 13. Cancer and metabolism ; SECTION 2: ETIOLOGY AND EPIDEMIOLOGY OF CANCER ; 14. Smoking and cancer ; 15. Viruses ; 16. Chemical carcinogens ; 17. Radiation ; 18. Body fatness, physical activity, diet, and other lifestyle factors ; SECTION 3: PRINCIPLES OF ONCOLOGY ; 19. Practice points for surgical oncology ; 20. Practice points for radiation oncology ; 21. Principles of chemotherapy ; 22. Delivery of multidisciplinary cancer care ; 23. Principles of clinical pharmacology: Introduction to pharmacokinetics and pharmacodynamics ; 24. Design and analysis of clinical trials ; 25. Medical ethics in oncology ; 26. Health economic assessment of cancer therapy ; SECTION 4: POPULATION HEALTH ; 27. Cancer control: The role of national plans ; 28. Cancer prevention: Vaccination ; 29. Cancer prevention: Chemoprevention ; 30. Population cancer screening ; 31. Familial cancer syndromes and genetic counselling ; SECTION 5: SUPPORT FOR THE CANCER PATIENT ; 32. Supportive palliative care ; 33. Quality of life ; 34. Cancer survivorship and rehabilitation ; SECTION 6: DISEASE ; 35. Cancer of the head and neck ; 36. Oesophageal cancer ; 37. Gastric cancer ; 38. Rectal cancer ; 39. Colon cancer ; 40. Pancreatic cancer ; 41. Hepatobiliary cancer ; 42. Peritoneal mesothelioma ; 43. Cancer of the breast ; 44. Gynaecological cancers ; 45. Genitourinary cancer ; 46. Lung cancer ; 47. Neoplasms of the thymus ; 48. Pleural mesothelioma ; 49. Skin cancer: melanoma ; 50. Skin cancer: non-melonoma ; 51. Acute leukemia ; 52. Chronic leukemias ; 53. Myeloma ; 54. Lymphomas ; 55. Sarcomas of the soft tissue ; 56. Cancer of the central nervous system ; 57. Cancer of the eye and orbit ; 58. Endocrine cancers ; 59. Cancer of unknown primary site ; INDEX